127 related articles for article (PubMed ID: 18396008)
1. Trastuzumb exposure during pregnancy.
Weber-Schoendorfer C; Schaefer C
Reprod Toxicol; 2008 Apr; 25(3):390-1; author reply 392. PubMed ID: 18396008
[No Abstract] [Full Text] [Related]
2. Herceptin therapy in pregnancy: continuation of pregnancy in the presence of anhydramnios.
Warraich Q; Smith N
J Obstet Gynaecol; 2009 Feb; 29(2):147-8. PubMed ID: 19274553
[No Abstract] [Full Text] [Related]
3. Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios.
Beale JM; Tuohy J; McDowell SJ
Am J Obstet Gynecol; 2009 Jul; 201(1):e13-4. PubMed ID: 19398090
[TBL] [Abstract][Full Text] [Related]
4. Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review.
Shrim A; Garcia-Bournissen F; Maxwell C; Farine D; Koren G
Reprod Toxicol; 2007 Jun; 23(4):611-3. PubMed ID: 17399946
[TBL] [Abstract][Full Text] [Related]
5. Effect of adjuvant trastuzumab on pregnancy.
Waterston AM; Graham J
J Clin Oncol; 2006 Jan; 24(2):321-2. PubMed ID: 16401684
[No Abstract] [Full Text] [Related]
6. Ectopic pregnancy in a breast cancer patient receiving trastuzumab.
Berveiller P; Mir O; Sauvanet E; Antoine EC; Goldwasser F
Reprod Toxicol; 2008 Feb; 25(2):286-8. PubMed ID: 18201867
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy in patients with breast cancer during pregnancy.
Loibl S
Cancer Treat Res; 2009; 151():317-28. PubMed ID: 19593521
[No Abstract] [Full Text] [Related]
8. Trastuzumab--mechanism of action and use.
Mir O; Berveiller P; Pons G
N Engl J Med; 2007 Oct; 357(16):1664-5; author reply 1665-6. PubMed ID: 17948347
[No Abstract] [Full Text] [Related]
9. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios.
Watson WJ
Obstet Gynecol; 2005 Mar; 105(3):642-3. PubMed ID: 15738038
[TBL] [Abstract][Full Text] [Related]
10. Trastuzamab (Herceptin)-related cardiotoxicity in pregnancy.
Roberts NJ; Auld BJ
J R Soc Med; 2010 Apr; 103(4):157-9. PubMed ID: 20382907
[No Abstract] [Full Text] [Related]
11. Trastuzumab in pregnancy associated with poor fetal outcome.
Witzel ID; Müller V; Harps E; Janicke F; Dewit M
Ann Oncol; 2008 Jan; 19(1):191-2. PubMed ID: 18084047
[No Abstract] [Full Text] [Related]
12. [Healing in sight?].
Jackisch C
Krankenpfl J; 2005; 43(4-6):137. PubMed ID: 16171079
[No Abstract] [Full Text] [Related]
13. Cancer drug may cause heart failure.
Gottlieb S
BMJ; 2000 Jul; 321(7256):259. PubMed ID: 10915118
[No Abstract] [Full Text] [Related]
14. Brain metastases in patients receiving trastuzumab for breast cancer.
Salmaggi A; Silvani A; Boiardi A
Neurol Sci; 2007 Mar; 28(1):1. PubMed ID: 17385088
[No Abstract] [Full Text] [Related]
15. Update on administration of adjuvant trastuzumab.
McArthur HL
Clin Adv Hematol Oncol; 2010 May; 8(5):321-2, 375. PubMed ID: 20551890
[No Abstract] [Full Text] [Related]
16. Learn to assess for and manage trastuzumab-induced cardiotoxicity.
Becze E
ONS Connect; 2009 Dec; 24(12):12-3. PubMed ID: 20039567
[No Abstract] [Full Text] [Related]
17. Brain metastases in patients receiving trastuzumab for breast cancer.
Errante D; Bernardi D; Bianco A; Salvagno L
Neurol Sci; 2007 Mar; 28(1):52-3. PubMed ID: 17385098
[No Abstract] [Full Text] [Related]
18. Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01).
Azim HA; Metzger-Filho O; de Azambuja E; Loibl S; Focant F; Gresko E; Arfi M; Piccart-Gebhart M
Breast Cancer Res Treat; 2012 May; 133(1):387-91. PubMed ID: 22367645
[TBL] [Abstract][Full Text] [Related]
19. Trastuzumab beyond progression: is the risk of cardiac toxicity really not increased?
Morabito A; Piccirillo MC; De Maio E; Di Maio M; Perrone F
J Clin Oncol; 2009 Sep; 27(27):e123; author reply e124-5. PubMed ID: 19687322
[No Abstract] [Full Text] [Related]
20. Did a monoclonal antibody cause this patient's death?
Porterfield LM
RN; 2000 Sep; 63(9):119. PubMed ID: 11040787
[No Abstract] [Full Text] [Related]
[Next] [New Search]
